Author:
Rohaan M.W.,Gomez-Eerland R.,van den Berg J.H.,Geukes Foppen M.H.,van Zon M.,Raud B.,Jedema I.,Scheij S.,de Boer R.,Bakker N.A.M.,van den Broek D.,Pronk L.M.,Grijpink-Ongering L.G.,Sari A.,Kessels R.,van den Haak M.,Mallo H.A.,Karger M.,van de Wiel B.A.,Zuur C.L.,Duinkerken C.W.,Lalezari F.,van Thienen J.V.,Wilgenhof S.,Blank C.U.,Beijnen J.H.,Nuijen B.,Schumacher T.N.,Haanen J.B.A.G.
Subject
Oncology,Immunology and Allergy
Reference44 articles.
1. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N Engl J Med,2019
2. Treatment of uveal melanoma: where are we now?;Yang;Ther Adv Med Oncol,2018
3. Overall survival benefit with tebentafusp in metastatic uveal melanoma;Nathan;N Engl J Med,2021
4. Adoptive cellular therapy: a race to the finish line;June;Sci Transl Med,2015
5. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead;Kirtane;J Immunother Cancer,2021
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献